Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
Caption: Jon Soderstrom and Jiasen Xu, CEO of SurExam ink the licensing agreement for commercialization of the technology for EOC detection developed by Gil Mor (upper left), while Carolyn Slayman, Deputy Dean of Yale Medical School and Zhinan Yin observe.
Credit: J.Damian/Yale
Usage Restrictions: with credit cited
Related news release: Yale ovarian cancer detection technology licensed in China by SurExam